Skip to main content
TipRanks
Go Ultimate75% OFF

China Resources Pharmaceutical Group Ltd. (3320) Income Statement

4 Followers

China Resources Pharmaceutical Group Ltd. Income Statement

Last quarter (Q2 2026), China Resources Pharmaceutical Group Ltd.'s total revenue was ¥153.28B, an increase of 9.99% from the same quarter last year. In Q2, China Resources Pharmaceutical Group Ltd.'s net income was ¥2.49B. See China Resources Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 300.01B¥ 274.18B¥ 270.40B¥ 223.13B¥ 193.24B
¥ 49.53B¥ 43.30B¥ 42.43B¥ 34.36B¥ 28.87B
¥ 35.63B¥ 30.73B¥ 30.52B¥ 24.87B¥ 21.32B
Depreciation and Amortization¥ 4.47B¥ 3.61B¥ 3.42B¥ 2.77B¥ 2.35B
¥ 18.55B¥ 16.36B¥ 15.34B¥ 13.59B¥ 9.79B
¥ 13.90B¥ 12.56B¥ 13.90B¥ 9.49B¥ 7.55B
¥ -774.39M¥ -931.88M¥ -2.97B¥ -840.13M¥ -685.79M
¥ 13.13B¥ 11.63B¥ 10.94B¥ 8.65B¥ 6.86B
¥ 4.50B¥ 3.57B¥ 4.24B¥ 3.64B¥ 3.08B
Per Share Metrics
Basic EPS¥ 0.72¥ 0.56¥ 0.68¥ 0.55¥ 0.49
Diluted EPS¥ 0.72¥ 0.56¥ 0.68¥ 0.55¥ 0.49
Weighted Average Shares Outstanding6.28B6.28B6.28B6.28B6.28B
Weighted Average Shares Outstanding (Diluted)6.28B6.28B6.28B6.28B6.28B

Currency in CNY

China Resources Pharmaceutical Group Ltd. Earnings and Revenue History

0120B240B360B1.2 %1.6 %2 %2.4 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin